Mega Lifesciences PCL
SET:MEGA
Mega Lifesciences PCL
Other Liabilities
Mega Lifesciences PCL
Other Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Mega Lifesciences PCL
SET:MEGA
|
Other Liabilities
฿301m
|
CAGR 3-Years
11%
|
CAGR 5-Years
5%
|
CAGR 10-Years
13%
|
|
|
B
|
Bangkok Lab and Cosmetic PCL
SET:BLC
|
Other Liabilities
฿142.7m
|
CAGR 3-Years
10%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Mega Lifesciences PCL
Glance View
Mega Lifesciences Public Co. Ltd. engages in the manufacture, market, sale, and distribution of pharmaceutical, nutraceutical products, and consumer goods. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2013-11-19. The firm's products include complimentary medicines, over-the-counter (OTC) medicines and prescription medicines to both domestic and international markets. The company distributes products under Maxxcare brand covering prescription pharmaceutical products, OTC drugs and other consumer products. The firm also offers nutritional products, prescription pharmaceutical products and OTC drugs under Mega We Care brand. In addition, the Company operates as an original equipment manufacturer (OEM) for various products including health supplements, pharmaceutical, herbal products, vitamins and minerals, among others.
See Also
What is Mega Lifesciences PCL's Other Liabilities?
Other Liabilities
301m
THB
Based on the financial report for Dec 31, 2025, Mega Lifesciences PCL's Other Liabilities amounts to 301m THB.
What is Mega Lifesciences PCL's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
13%
Over the last year, the Other Liabilities growth was 8%. The average annual Other Liabilities growth rates for Mega Lifesciences PCL have been 11% over the past three years , 5% over the past five years , and 13% over the past ten years .
